Barclays Maintains Underweight on NOV, Lowers Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst David Anderson maintains an Underweight rating on NOV and lowers the price target from $17 to $16.
October 29, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays analyst David Anderson has maintained an Underweight rating on NOV and reduced the price target from $17 to $16, indicating a bearish outlook.
The reduction in price target from $17 to $16 by Barclays suggests a negative outlook on NOV's stock performance. Maintaining an Underweight rating further indicates that the analyst expects the stock to underperform relative to the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100